Fansidar and hepatic granulomas.
D000368:Aged; D000962:Antimalarials / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000473:pathology*; D004338:Drug Combinations / Q000009:adverse effects; D005260:Female; D006099:Granuloma / Q000139:chemically induced*; D006801:Humans; D011739:Pyrimethamine / Q000009:adverse effects*; D013413:Sulfadoxine / Q000009:adverse effects*; D013424:Sulfanilamides / Q000009:adverse effects*
D000962:Antimalarials; D004338:Drug Combinations; D013424:Sulfanilamides; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D011739:Pyrimethamine